Balazs Szigeti - The influence of expectancy and suggestibility in psychedelic medicine

Psychedelic clinical trials often face significant challenges regarding blinding due to the potent subjective effects that allow participants to easily distinguish between an active substance and a placebo. This tendency compromises the reliability of double-blind randomized controlled studies. The failure to account for participant expectancy can lead to inflated claims about substance efficacy, as subjective expectations significantly influence reported outcomes. Accounting for expectation and suggestibility is vital for future research methodology. Researchers should include methods to monitor and adjust for participant guesses regarding their treatment allocation, ensuring a rigorous evaluation of the therapeutic potential of these substances in modern medicine.